No registrations found.
ID
Source
Brief title
Health condition
Oudere kankerpatiënten, kwaliteit van leven, ongewenste bijwerkingen, monitoring.
Senior cancer patients, quality of life, adverse reactions, monitoring.
Sponsors and support
Intervention
Outcome measures
Primary outcome
Less unexpected hopitalizations
Secondary outcome
-Patient reported outcome (PROM) about intensive monitoring
-Hospital replaced care in transmural collaboration
-Implentation of a web-based platform for intensive monitoring of treatment related advers events
-Knowledge on possible differences between Dutch regions and community versus university hospital
-Comparison of data from Easycare-Tos with the two screeningsinstrument used in older cancer patients (G8 en GFI) and data from a limited geriatric assessment (IADL, GDS and MNA)
Background summary
Background:
Systemic therapy (cytostatic and/or targeted treatment) can be beneficial tot cancer patients, regardless of age, however, older patients are at risk for treament-related toxicity. Treatment related side-effect and unplanned hospital admissions (UHA) have a major impact on QoL, threatening independence. Treatment side-effects often lead to dose reductions, and in older patients even low grade toxicities (grade I/II) lead frequently to treatment modifications.
Objective
The aim of this study is to maintain QoL an improve cancer related outcome by preventing therapy-related toxicity (and ensuing unplanned hospital admission and/or discontinuation of chemotherapy) in cancer patients treated with systemic therapy bij the following procedures:
1. Integration of care/transmural collaboration.
2. Integrating "Hereismydata"in daily care to monitor treatment-related toxicity.
3. Education of home care providers to provide them tools to adequately intervene/ counsel oncology patients by developing a teaching module.
4.Evaluation of the use of Easycare-Tos in cancer patients.
5. Exploring patients preferences on care by hospital nurse, POH, district nurse an use of the internet.
Study population:
Older patients (aged 70 years or older) scheduled for systemic cancer treatment
Study objective
The aim of this project is to maintain quality of life and improve cancer related outcome by preventing therapy-related toxicity (and ensuing unplanned hospital admission and/or discontinuation of chemotherapy) in cancer patients treated with systemic therapy
Study design
-Before treatment (30-45 minutes)
-After 2 cycles and 3 months and after treatment finished (15 minutes at a time)
-During treatment there will be frequently contacts with the oncology nurse
Intervention
Intensive monitoring by screening tests; geriatric assesment / QoL / outcome measures
Department of Pulmonary Diseases
A.N.M. Wymenga
Haaksbergerstraat 55
Enschede 7513 ER
The Netherlands
Department of Pulmonary Diseases
A.N.M. Wymenga
Haaksbergerstraat 55
Enschede 7513 ER
The Netherlands
Inclusion criteria
- Treatment with chemotherapy/targeted
therapy
- Aged 70 years or older
- Signed informed consent
Exclusion criteria
-Insufficient command on the Dutch language
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4506 |
| NTR-old | NTR4624 |
| CCMO | NL48682.044.14 |
| OMON | NL-OMON44642 |